My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biogen Idec (NQ:BIIB)

154.04 -0.18 (-0.12%)
Streaming Delayed Price Updated: 11:41 AM EDT, Oct 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,125,868
Open 154.00
Bid (Size) 153.84 (1)
Ask (Size) 154.23 (2)
Prev. Close 154.22
Today's Range 152.22 - 157.85
52wk Range 110.03 - 195.00
Shares Outstanding 145,800,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Low-Volatility Stocks That Concern Us
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
A Look Back at Therapeutics Stocks’ Q2 Earnings: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Pack
Looking back on therapeutics stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Myriad Genetics (NASDAQ:MYGN) and its peers. 
Via StockStory
Topics Artificial Intelligence

Performance

YTD
+2.7%
+2.7%
1 Month
+10.3%
+10.3%
3 Month
+15.7%
+15.7%
6 Month
+17.3%
+17.3%
1 Year
-19.3%
-19.3%

More News

Read More
Biogen Soars 9.02% on Groundbreaking Alzheimer's Drug Advancements: A New Era for Dementia Treatment Dawns
Via MarketMinute
A Look Into Biogen Inc's Price Over Earnings
Via Benzinga
Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years
Via Benzinga
Topics Government
Wednesday's session: top gainers and losers in the S&P500 index
Via Chartmill
Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday?
Via Benzinga
Which S&P500 stocks are moving on Wednesday?
Via Chartmill
Dow Futures Defy Shutdown Fears: A Deep Dive into Market Resilience
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in China
From Biogen Inc.
Via GlobeNewswire
Incannex Healthcare (NASDAQ: IXHL) Braces for Volatility as Q4 Earnings Loom: Options Traders Eye Strategic Plays
Via MarketMinute
Topics Artificial Intelligence Earnings
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
Via Benzinga
Topics Government World Trade
Trump Shocks Pharma With 100% Tariff On Imported Drugs Unless Companies Build In America
Via Stocktwits
Topics Government
Biogen Faces FDA Setback On High-Dose Nusinersen Filing For Spinal Muscular Atrophy
Via Benzinga
This Lululemon Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
Via Benzinga
This Biogen Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
What 6 Analyst Ratings Have To Say About Biogen
Via Benzinga
LEQEMBI® (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Australia
From Biogen Inc.
Via GlobeNewswire
Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen
From Biogen Inc.
Via GlobeNewswire
Unpacking Q2 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
Biogen's $85 Million Deal Could Change How Patients Get Spinraza Treatment
Via Benzinga
Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidates
From Biogen Inc.
Via GlobeNewswire
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
From Biogen Inc.
Via GlobeNewswire
Firing on All Cylinders: Biogen (NASDAQ:BIIB) Q2 Earnings Lead the Way
Via StockStory
Topics Artificial Intelligence
Reflecting On Therapeutics Stocks’ Q2 Earnings: BioMarin Pharmaceutical (NASDAQ:BMRN)
Via StockStory
Topics Artificial Intelligence

Frequently Asked Questions

Is Biogen Idec publicly traded?
Yes, Biogen Idec is publicly traded.
What exchange does Biogen Idec trade on?
Biogen Idec trades on the Nasdaq Stock Market
What is the ticker symbol for Biogen Idec?
The ticker symbol for Biogen Idec is BIIB on the Nasdaq Stock Market
What is the current price of Biogen Idec?
The current price of Biogen Idec is 154.04
When was Biogen Idec last traded?
The last trade of Biogen Idec was at 10/02/25 11:41 AM ET
What is the market capitalization of Biogen Idec?
The market capitalization of Biogen Idec is 22.46B
How many shares of Biogen Idec are outstanding?
Biogen Idec has 22B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.